Clinical “real‐world” experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients

Overview of attention for article published in Clinical Transplantation, April 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

blogs: 1 blog
twitter: 10 X users

guideline: 2 clinical guideline sources

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 11 X posts from 10 X users, with an upper bound of 37,593 followers.

RT @drkomanduri: @TxID_Edu @Doctor_Yiannis @camwolfe @KottonNelson @MichaelGIsonMD @JoshuaHillMD @AndrewKaraba @DocWoc71 Multiple papers on…

@TxID_Edu @Doctor_Yiannis @camwolfe @KottonNelson @MichaelGIsonMD @JoshuaHillMD @AndrewKaraba @DocWoc71 Multiple papers on the subject but we published our experience a while ago. https://t.co/e5D4L7RDgx

RT @drkomanduri: Our postmarketing study of 25 alloSCT patients vs >100 historical controls. Bottom line is #letermovir works. Clinical “re…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.